Popular Articles
Stretch Mark

Medtronic Launches Clinical Trial To Improve Quality Of Care For Implantable Defibrillator Patients
Medtronic, Inc (NYSE: MDT) announced the launch of the Shock-Less clinical trial. This trial will identify ways physicians can improve the quality of care for patients through optimal application of device-based tools designed to reduce unnecessary shocks in patients with implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy-defibrillator (CRT-D) devices. Specifically, the Shock-Less study aims to create evidence that will increase the use of programming tools that reduce unnecessary shocks including features on Medtronic devices, such as Medtronic"s exclusive Lead Integrity Alert™ (LIA) and Anti-Tachycardia Pacing (ATP) During Charging™.
generic viagra online
Medicare Tapped For Savings To Cover Reform Costs, Again
In his weekly Internet and radio address Saturday, President Obama announced a plan to cut $313 billion in Medicare and Medicaid spending over the next decade as a way to raise money for overhauling the health care system and covering millions of the uninsured, the Los Angeles Times reports. The largest savings include "increased efficiencies in the system," cuts to subsidies paid to hospitals for treating the uninsured, cuts to prices the government pays for prescription drugs for seniors. The paper adds: "the proposal -- which includes potential cuts to hospitals, pharmaceutical companies and other providers -- also underscores the political delicacy of the administration"s search for money for a massive healthcare overhaul that could cost more than $1.2 trillion over the next decade" (Levey, 6/15).
News of the day
New Lab Test Offers Better Prediction Of HIV Microbicide Safety
Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. The researchers have also discovered why several supposedly "safe" microbicides made women more susceptible to HIV infection. The study appears today in the online version of the Journal of Infectious Diseases.
Cardiovascular

Industry Lobby Wars Heighten As Reform Efforts Progress

"Healthcare companies are spending millions of dollars and marshaling armies of lobbyists to influence a landmark debate in the U.S. Congress that could dramatically change the way they do business," Reuters reports. "Drugmakers, doctors, insurers and hospitals have opened their wallets, spending more than $1 million a day to buy a voice in the escalating political battle over what could be the broadest revamp of healthcare laws in decades." And "as the debate has unfolded, key lawmakers have seen a surge in campaign donations, and hundreds of lobbyists have jammed Capitol hallways and lined the reception room outside the Senate chamber to talk to lawmakers." Sheila Krumholz, executive director of the Center for Responsive Politics, says "there is a frenzy going on to get in your two cents worth before the legislation reaches the next stage." In addition to rallying health care groups such as the Pharmaceutical Research and Manufacturers of America, the American Medical Association and health insurers, "the proposals in Congress are far-reaching enough that a diverse array of industry groups unrelated to healthcare have also lobbied on the issue, from soft drink manufacturers worried about new taxes on sugary drinks to Realtors and funeral home directors worried about the impact on small businesses, the Center for Responsive Politics said. The industry is also a big campaign contributor to members of Congress. Five of the top 10 contributors to Senate Finance Committee Chairman Max Baucus, a key player in healthcare negotiations, have in recent years been drug or insurance companies, according to reports compiled by the center" (Whitesides, 7/30). Politico reports that "while the big fight in health care reform focuses on whether to create a government insurance program, scores of skirmishes are being waged by industry interest groups over the massive legislation"s smaller provisions. One case in point: a David and Goliath showdown between a small group of medical supply companies and big hospitals. The medical supply companies are pitching a plan they say will inject new competition into the hospital equipment purchases market and save consumers $100 billion annually. Their cause is led by one paid spokeswoman, an industry whistleblower and an attorney working for free. They"ve also recruited support from unions and progressives. Against them stands an industry that, according to the Center for Responsive Politics, has spent nearly $50 million in just the first six months of this year lobbying Congress. It"s also an industry that the White House and Congress desperately want on board in the reform effort" (Frates, 7/31). Newsweek blog "The Gaggle" reports that the ad wars between health care groups is likely to reach new heights over the August recess, especially in swing districts. "Pretty much every lobby with a stake in health care - big business, insurance, pharmaceutical companies, both political parties, among others - are planning a major blitz to try to shape the outcome of the bill. ... For lack of a better word, it"s going to be a total ad-pocalyse, along the likes of what we saw during the final weeks of the presidential campaign last fall" (Bailey, 7/30). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):